RLIP inhibition suppresses breast-to-lung metastasis

Jyotsana Singhal1, Shireen Chikara2, David Horne3

  • 1Department of Medical Oncology, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, 91010, USA; Department of Molecular Medicine, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, 91010, USA.

Cancer Letters
|January 27, 2019
PubMed

Insights

This study shows that 2'-hydroxyflavanone (2HF) combined with RLIP inhibition effectively suppresses breast tumor growth and lung metastasis. This combination therapy offers a promising strategy for treating aggressive breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Breast cancer metastasis, particularly to the lungs, is a major cause of cancer mortality.
  • Triple-negative breast cancer (TNBC) presents significant therapeutic challenges due to its aggressive nature and limited treatment options.
  • RLIP (Ras and␮-associated protein 1) is implicated in cancer cell proliferation and metastasis.

Purpose of the Study:

  • To investigate the anti-proliferative and anti-metastatic effects of 2 -hydroxyflavanone (2HF) and RLIP inhibition in triple-negative breast cancer (TNBC).
  • To evaluate the efficacy of combining 2HF with RLIP inhibition strategies (antisense oligonucleotide and antibody) in preclinical models.

Main Methods:

  • In vitro studies using TNBC cell lines to assess cell viability, migration, and invasion.
  • In vivo orthotopic mouse model of breast-to-lung metastasis using luciferase-expressing TNBC cells.
  • Treatment groups included 2HF, RLIP antisense (RAS), RLIP antibody (Rab), and combination therapies.

Main Results:

  • RLIP inhibition alone reduced in vitro cell viability, migration, and invasion.
  • 2HF treatment decreased the expression of RLIP, KRAS, pERK, pSTAT3, and pP70S6K in vitro.
  • Combined treatment with 2HF, RAS, and Rab significantly reduced primary tumor weight and completely abolished lung metastasis in mice, outperforming single-agent therapies.

Conclusions:

  • 2 -hydroxyflavanone (2HF) demonstrates significant anti-proliferative and anti-metastatic properties in TNBC models.
  • RLIP inhibition, via antisense or antibody, is effective in suppressing breast cancer progression and metastasis.
  • The combination of 2HF with RLIP inhibition presents a potent therapeutic strategy for overcoming breast tumor growth and lung metastasis.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
696